Tina Mahajan, MD | Internal Medicine | University of Nebraska Medical Center

Assistant Professor, Internal Medicine Division of Rheumatology Appointments: 402-559-4015
Primary Practice Location:	Brentwood Clinic
Practice Location(s):	Durham Outpatient Center
Research Interests:	Rheumatoid arthritis, autoimmune lung disease
Medical School:	2005 St. Louis University, St. Louis, MO
Residency:	2006 Internship in Internal Medicine, Baylor University, Dallas, TX 2009 Residency in Internal Medicine, Baylor University, Dallas, TX
Fellowship:	2010 Rheumatology Fellowship, UT Southwestern Medical Center, Dallas, TX
Bio Sketch:	Dr. Mahajan’s main interests are in clinical rheumatology, education, and clinical research. She practices at UNMC and the Brentwood Clinic. She has a special interest in rheumatoid arthritis (RA) and has helped develop the Early RA Lung Study, which is currently enrolling newly diagnosed patients with RA. Dr. Mahajan is also a part of the Autoimmune Lung Clinic at UNMC. She is involved in resident and fellow teaching and is an active member of the American College of Rheumatology. In her free time, she enjoys spending time with family.

Selected Publications / Current Publications:

Sandeep Singh, Tianfu Wu, Chung Xie, Kamala Vanarsa, Jie Han, Tina Mahajan, et al. (July 2012) Urine V-CAM 1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther.
Ramesh Saxena, Tina Mahajan, and Chandra Mohan (September 2011) Lupus Nephritis: Current Update. Arthritis Res Ther. Volume 13, issue 5.
Tina Mahajan and Andreas Reimold (October 2010) The Use of Abatacept in Patients with Chronic Hepatitis C: 2 Case Reports and Review of the Literature. Journal of Clinical Rheumatology. Volume 16, issue 7.
Tina Mahajan and Marvin Stone (April 2007) Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): report of a case with other autoimmune manifestations. Proc (Bayl Univ Med Cent.) Volume 20, number 2.
Monali Bhosle, Rajesh Balkrishnan, Tina Mahajan, and Steven Feldman (December 2005). The rise of the generic drug market and its implications for dermatology. Journal of Derm Treatment. Volume 16, 295-298.